Gliminac MV 2mg/500mg/0.3mg Tablet
Marketer
NACC Pharmaceutical Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Gliminac MV 2mg/500mg/0.3mg Tablet
Diabetic patients may use the anti-diabetic medication, Gliminac MV 2mg/500mg/0.3mg Tablet, to manage type 2 diabetes mellitus. This combination drug regulates blood glucose in adults. Administer this tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your healthcare provider. Lifestyle adjustments are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headaches, swelling (edema), blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (for blood cell counts and liver function) are recommended.
Uses of Gliminac MV 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Gliminac MV 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliminac MV 2mg/500mg/0.3mg tablets should be administered on an empty stomach.
Common Side effects of Gliminac MV 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Gliminac MV 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliminac MV 2mg/500mg/0.3mg tablets should be administered on an empty stomach.
How Gliminac MV 2mg/500mg/0.3mg Tablet works:
Gliminac MV tablets, containing 2mg/500mg/0.3mg of a triple-action antidiabetic formulation, combine three distinct medications.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gliminac MV 2mg/500mg/0.3mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gliminac MV 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Patient consultation with their doctor is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Gliminac MV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available data from humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Gliminac MV 2mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Patients with severe kidney disease should not take Gliminac MV 2mg/500mg/0.3mg tablets.
LiverCAUTION
Patients with liver impairment should use Gliminac MV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typical; however, the medication is unsuitable for individuals with severe liver dysfunction.
What if you forget to take Gliminac MV 2mg/500mg/0.3mg Tablet :
Should you forget a Gliminac MV 2mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliminac MV 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently